Avid Bioservices Stock (NASDAQ: CDMO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.04M |
Day Range | - - - |
52 Wk Range | 4.07 - 12.48 |
Market Cap | $740.02M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 20.53% |
Days to Cover | 24.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avid Bioservices (NASDAQ:CDMO) through any online brokerage.
Other companies in Avid Bioservices’s space includes: Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), 4D Molecular Therapeutics (NASDAQ:FDMT), Replimune Group (NASDAQ:REPL) and Mesoblast (NASDAQ:MESO).
Avid Bioservices has a consensus price target of $13.50.
The stock price for Avid Bioservices (NASDAQ: CDMO) is $11.6 last updated September 20, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Avid Bioservices.
Avid Bioservices’s Q2 earnings are confirmed for Thursday, December 5, 2024.
There is no upcoming split for Avid Bioservices.
Avid Bioservices is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.